FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076983947> ?p ?o ?g. }

• W2076983947 endingPage "547" @default.
• W2076983947 startingPage "534" @default.
• W2076983947 abstract "1. The absorption, metabolism and excretion of darexaban (YM150), a novel oral direct factor Xa inhibitor, were investigated after a single oral administration of [14C]darexaban maleate at a dose of 60 mg in healthy male human subjects.2. [14C]Darexaban was rapidly absorbed, with both blood and plasma concentrations peaking at approximately 0.75 h post-dose. Plasma concentrations of darexaban glucuronide (M1), the pharmacological activity of which is equipotent to darexaban in vitro, also peaked at approximately 0.75 h.3. Similar amounts of dosed radioactivity were excreted via faeces (51.9%) and urine (46.4%) by 168 h post-dose, suggesting that at least approximately half of the administered dose is absorbed from the gastrointestinal tract.4. M1 was the major drug-related component in plasma and urine, accounting for up to 95.8% of radioactivity in plasma. The N-oxides of M1, a mixture of two diastereomers designated as M2 and M3, were also present in plasma and urine, accounting for up to 13.2% of radioactivity in plasma. In faeces, darexaban was the major drug-related component, and N-demethyl darexaban (M5) was detected as a minor metabolite.5. These findings suggested that, following oral administration of darexaban in humans, M1 is quickly formed during first-pass metabolism via UDP-glucuronosyltransferases, exerting its pharmacological activity in blood before being excreted into urine and faeces." @default.
• W2076983947 created "2016-06-24" @default.
• W2076983947 creator A5008722654 @default.
• W2076983947 creator A5011678883 @default.
• W2076983947 creator A5011984391 @default.
• W2076983947 creator A5013182043 @default.
• W2076983947 creator A5030497460 @default.
• W2076983947 creator A5036118031 @default.
• W2076983947 creator A5039713170 @default.
• W2076983947 creator A5045516670 @default.
• W2076983947 creator A5065668193 @default.
• W2076983947 creator A5078368371 @default.
• W2076983947 creator A5085070792 @default.
• W2076983947 date "2012-11-20" @default.
• W2076983947 modified "2023-10-16" @default.
• W2076983947 title "Absorption, metabolism and excretion of darexaban (YM150), a new direct factor Xa inhibitor in humans" @default.
• W2076983947 cites W152943885 @default.
• W2076983947 cites W1943527316 @default.
• W2076983947 cites W1968098782 @default.
• W2076983947 cites W1977418630 @default.
• W2076983947 cites W1986131884 @default.
• W2076983947 cites W2004801166 @default.
• W2076983947 cites W2015745909 @default.
• W2076983947 cites W2022289628 @default.
• W2076983947 cites W2023538018 @default.
• W2076983947 cites W2056928979 @default.
• W2076983947 cites W2066736865 @default.
• W2076983947 cites W2068476516 @default.
• W2076983947 cites W2096169020 @default.
• W2076983947 cites W2127955110 @default.
• W2076983947 cites W2137422676 @default.
• W2076983947 cites W2159370562 @default.
• W2076983947 cites W2328130719 @default.
• W2076983947 doi "https://doi.org/10.3109/00498254.2012.738045" @default.
• W2076983947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23167531" @default.
• W2076983947 hasPublicationYear "2012" @default.
• W2076983947 type Work @default.
• W2076983947 sameAs 2076983947 @default.
• W2076983947 citedByCount "14" @default.
• W2076983947 countsByYear W20769839472013 @default.
• W2076983947 countsByYear W20769839472014 @default.
• W2076983947 countsByYear W20769839472015 @default.
• W2076983947 countsByYear W20769839472017 @default.
• W2076983947 countsByYear W20769839472018 @default.
• W2076983947 countsByYear W20769839472019 @default.
• W2076983947 countsByYear W20769839472020 @default.
• W2076983947 crossrefType "journal-article" @default.
• W2076983947 hasAuthorship W2076983947A5008722654 @default.
• W2076983947 hasAuthorship W2076983947A5011678883 @default.
• W2076983947 hasAuthorship W2076983947A5011984391 @default.
• W2076983947 hasAuthorship W2076983947A5013182043 @default.
• W2076983947 hasAuthorship W2076983947A5030497460 @default.
• W2076983947 hasAuthorship W2076983947A5036118031 @default.
• W2076983947 hasAuthorship W2076983947A5039713170 @default.
• W2076983947 hasAuthorship W2076983947A5045516670 @default.
• W2076983947 hasAuthorship W2076983947A5065668193 @default.
• W2076983947 hasAuthorship W2076983947A5078368371 @default.
• W2076983947 hasAuthorship W2076983947A5085070792 @default.
• W2076983947 hasConcept C10146269 @default.
• W2076983947 hasConcept C112705442 @default.
• W2076983947 hasConcept C121332964 @default.
• W2076983947 hasConcept C125287762 @default.
• W2076983947 hasConcept C126322002 @default.
• W2076983947 hasConcept C134018914 @default.
• W2076983947 hasConcept C149151106 @default.
• W2076983947 hasConcept C151730666 @default.
• W2076983947 hasConcept C185592680 @default.
• W2076983947 hasConcept C24890656 @default.
• W2076983947 hasConcept C2776575606 @default.
• W2076983947 hasConcept C2777056448 @default.
• W2076983947 hasConcept C2777477808 @default.
• W2076983947 hasConcept C2779186261 @default.
• W2076983947 hasConcept C2780026642 @default.
• W2076983947 hasConcept C55493867 @default.
• W2076983947 hasConcept C61716771 @default.
• W2076983947 hasConcept C62231903 @default.
• W2076983947 hasConcept C71924100 @default.
• W2076983947 hasConcept C86803240 @default.
• W2076983947 hasConcept C98274493 @default.
• W2076983947 hasConceptScore W2076983947C10146269 @default.
• W2076983947 hasConceptScore W2076983947C112705442 @default.
• W2076983947 hasConceptScore W2076983947C121332964 @default.
• W2076983947 hasConceptScore W2076983947C125287762 @default.
• W2076983947 hasConceptScore W2076983947C126322002 @default.
• W2076983947 hasConceptScore W2076983947C134018914 @default.
• W2076983947 hasConceptScore W2076983947C149151106 @default.
• W2076983947 hasConceptScore W2076983947C151730666 @default.
• W2076983947 hasConceptScore W2076983947C185592680 @default.
• W2076983947 hasConceptScore W2076983947C24890656 @default.
• W2076983947 hasConceptScore W2076983947C2776575606 @default.
• W2076983947 hasConceptScore W2076983947C2777056448 @default.
• W2076983947 hasConceptScore W2076983947C2777477808 @default.
• W2076983947 hasConceptScore W2076983947C2779186261 @default.
• W2076983947 hasConceptScore W2076983947C2780026642 @default.
• W2076983947 hasConceptScore W2076983947C55493867 @default.
• W2076983947 hasConceptScore W2076983947C61716771 @default.
• W2076983947 hasConceptScore W2076983947C62231903 @default.
• W2076983947 hasConceptScore W2076983947C71924100 @default.

• next